ALLERGIK KASALLIKLARNI DAVOLASH VA PROFILAKTIKASIDA ALLERGEN- SPESIFIK IMMUNOTERAPIYANING TURLI USULLARINING KLINIK SAMARADORLIGINI BAHOLASH (ILG‘OR TADQIQOTLAR SHARHI ASOSIDA)

Perevoshchikova, Nina Konstantinovna, et al. "Early postnatal correction of intestinal microbiota as the main factor in primary prevention of atopy (methodological recommendations for doctors)." Mother and Child in Kuzbass 1 (84) (2021): 108-127.

S. Singh, B. B. Sharma, S. Salvi et al. // Allergic rhinitis, rhinoconjunctivitis, and eczema: prevalence and associated factors in children / Clin. Respir. J. - 2018. - Vol. 12, No. 2. - P. 547-556.

C. Muche-Borowski, M. Kopp, I. Reese et al. // Allergy prevention / Dtsch. Arztebl. Int. — 2009. — Bd. 106, No. 39. — P. 625–631.

Helem K. Riddel et al “Global strategy for asthma and management and prevention” 2024 -P. 14 https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf

Smirnov D. S., Kurbacheva O. M. Modern view on the therapy of allergic rhinitis in its combination with bronchial asthma // Medical Council. – 2021. – No. 6. – P. 92-98.

Gladkov S. F. “Realization of atopy in conditions of environmental distress and approaches to its prevention’’ dissertasiya 2021. –P.5

Babadzhanova Z. Buxoro viloyatida respirator allergik kasalliklarning epidеmiologiyasi //Medical science of Uzbekistan. – 2022. – No. 2. – P. 21-23.

Khabibullayevna M. M., Murotkhonovna S. A. Changes in the quality of life indicators of patients when allergic rhinitis is comorbid with bronchial asthma in children //journal of biomedicine and practice. – 2023. – T. 8. – No. 3.

Pawankar R., Akdis C. A. Climate change and the epithelial barrier theory in allergic diseases: A One Health approach to a green environment //Allergy. – 2023. – T. 78. – No. 11. – P. 2829-2834. https://doi.org/10.1111/all.15885

Mirraximova M. X., Saidxonova A. M. Occurrence of atopic diseases in children in ecologically disadvantaged areas of Uzbekistan // Problems of Biology and Medicine. Samarkand. – 2020. – T. 2. – P. 84-87.

Kh M. M. Saidkhonova A. M. Optimization of Allergic Rhinitis Therapy in Children //The American journal of Medical sciences and Pharmaceutical Research (tajmspr) Sjif-5.286 Doi-10.37547/tajmsp. – 2020. – No. 2. – P. 119-125.

Moote W., Kim H., Ellis A. K. Allergen-specific immunotherapy //Allergy, Asthma & Clinical Immunology. – 2018. – T. 14. – P. 1-10.

Kucuksezer U. C. et al. Mechanisms of allergen-specific immunotherapy and allergen tolerance //Allergology International. – 2020. – T. 69. – No. 4. – P. 549-560.

Zissler U. M., Schmidt-Weber C. B. Predicting success of allergen-specific immunotherapy // Frontiers in Immunology. – 2020. – T. 11. – P. 1826. https://doi.org/10.3389/fimmu.2020.01826

Jutel M. et al. Allergen-specific immunotherapy with recombinant grass pollen allergens // Journal of Allergy and Clinical Immunology. – 2005. – T. 116. – No. 3. – P. 608-613. https://doi.org/10.1016/j.jaci.2005.06.004

Calderon M. A. et al. Allergen injection immunotherapy for seasonal allergic rhinitis // Cochrane database of systematic reviews. – 2007. – No. 1. https://doi.org/10.1002/14651858.CD001936.pub2

Mirrakhimova M. et al. Allergo-immunological characteristics of comorbid passage of allergic rhinitis in children //BIO Web of Conferences. – EDP Sciences, 2023. – T. 65. – P. 05007.https://doi.org/10.1051/bioconf/20236505007

Dhami S. et al. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis //Allergy. – 2017. – T. 72. – No. 12. – P. 1825-1848. https://doi.org/10.1111/all.13208

Wilson D. R., Torres Lima M., Durham S. R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis // Allergy. – 2005. – T. 60. – No. 1. – P. 4 12. https://doi.org/10.1111/j.1398-9995.2005.00699.x

Olaguibel J. M., Alvarez Puebla M. J. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis //J Investig Allergol Clin Immunol. – 2005. – T. 15. – No. 1. – pp. 9-16.

Penagos M. et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials // Annals of Allergy, Asthma & Immunology. – 2006. – T. 97. – No. 2. – P. 141-148. https://doi.org/10.1016/S1081-1206(10)60004-X

Compalati E. et al. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA²LEN meta-analysis //Allergy. – 2009. – T. 64. – No. 11. – P. 1570-1579.

https://doi.org/10.1111/j.1398-9995.2009.02129.x

Dhami S. et al. Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis //Allergy. – 2017. – T. 72. – No. 12. – P. 1825-1848. https://doi.org/10.1111/all.13208

Halken S. et al. EAACI guidelines on allergen immunotherapy: prevention of allergy //Pediatric Allergy and Immunology. – 2017. – T. 28. – No. 8. – P. 728-745.

Gunawardana N. C., Durham S. R. New approaches to allergen immunotherapy // Annals of Allergy, Asthma & Immunology. – 2018.– T. 121. – No. 3. – P. 293-305.